Jaguar Health, Inc. - Common Stock (JAGX)
$0.67
0.04 (4.97%)
JAGX Stock Quote Delayed 30 Minutes
Is Jaguar Health Ready to Bounce Back From a Lousy February?
Jaguar Health did not have a good February. Down 25% through Feb. 25, it might be time to give up on JAGX stock despite SPAC spinoff.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
115.61M
PE Ratio
-0.14
EPS
-4.73
Volume (Avg. Vol.)
312,096
Day's Range
$0.67 - $0.76
52-Week Range
$0.70 - $21.60
Dividend & Yield
N/A (N/A)
JAGX Stock Predictions, Articles, and Jaguar Health, Inc. - Common Stock News
Hold Jaguar Health Stock for SPAC Spin-Off and Covid-19 Connection
JAGX stock holders must weigh the impact of an intriguing European SPAC and a potential treatment option for Covid-19 long-haul patients.
Jaguar Health Has a Strong Outline, But the Story Is Unclear
The 12-month, 300% gain with JAGX stock has a lot of headline news. There’s a lot to like, but will Jaguar be able to build on its gains?
Jaguar Health Isn’t a Healthy Investment, but It Could Be a Profitable One
Likely, no one would suggest that JAGX stock is a fundamentally sound investment. But the current market environment makes shares a compelling short-term trade.
Jaguar Health Stock Remains a Speculative Investment At Best
Jaguar Health stock is a speculative investment at best. JAGX stock is hard to nail down as it’s hard to understand its numerous and strange financings.
Do We Know Enough About Napo Pharma’s SPAC To Invest In Jaguar Health?
Jaguar Health might merge part of its Napo Pharmaceuticals unit with a SPAC. What’s this mean for JAGX stock over the long haul?
JAGX Stock: Jaguar Health’s Napo EU to Go Public Via SPAC
JAGX stock may be slumping today, but new SPAC merger news could turn things around. Here is what you should know about the Napo EU deal now.
Proposed SPAC Merger Makes Jaguar Health Stock Intriguing
If you've been sitting on the sidelines when it comes to JAGX stock, an important meeting should give you the excuse you've been waiting for.
What You Need to Know About Jaguar Health Stock
Jaguar Health is showing better vital signs lately. However, there are still some things to consider before pouncing on JAGX stock.
JAGX Stock Surges Ahead of Jaguar Health SPAC Merger Meeting
Jaguar Health (JAGX) stock is on the rise Thursday after announcing a meeting concerning an upcoming SPAC merger in Italy.
Don’t Try to Tame Jaguar Health Stock As It Rips Higher
If you believe in the future of plant-based medical treatments, then a long position in JAGX stock could offer exposure to this technology.
JAGX Stock: 11 Things to Know as Jaguar Health Rockets Higher
JAGX stock is on the move today as Jaguar Health continues to gain attention. Here's what you should know about the biopharma play now.
JAGX Stock: 12 Things to Know About Fast-Moving Jaguar Health
JAGX shares are once again on the move this week. Here's what you should know about the maker of the antidiarrheal treatment Mytesi.
JAGX Stock: Why Jaguar Health Shares Are Surging 150% Today
JAGX stock is up on news that Jaguar Health just signed a royalty deal that will allow the company to pursue new FDA approvals.
Jaguar Health: 10 Things for JAGX Stock Investors to Know About the Pharmaceutical Company
Jaguar Health (JAGX) is on the move Tuesday as shares of JAGX stock continue to rise and InvestorPlace has what investors need to know.
13 Pharmaceuticals Stocks to Sell Now
The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
19 Pharmaceuticals Stocks to Sell Now
This week, the overall grades of 19 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Hottest Manufacturing Stocks Now – JAGX GBIM PRTK TROX
The following stocks were moving the Manufacturing sector today.
Hottest Manufacturing Stocks Now – SHLO HTCH STS OPXA
The following stocks were moving the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – JAGX BLPH KMG GIG
The following stocks were moving the Manufacturing sector today.
